Accustem Sciences Financials
| ACUT Stock | USD 0.30 0.04 11.76% |
With this module, you can analyze Accustem financials for your investing period. You should be able to track the changes in Accustem Sciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Accustem |
Understanding current and past Accustem Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Accustem Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Accustem Sciences' assets may result in an increase in income on the income statement.
The data published in Accustem Sciences' official financial statements typically reflect Accustem Sciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Accustem Sciences' quantitative information. For example, before you start analyzing numbers published by Accustem accountants, it's essential to understand Accustem Sciences' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in Accustem Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Accustem Sciences. Check Accustem Sciences' Beneish M Score to see the likelihood of Accustem Sciences' management manipulating its earnings.
Accustem Sciences Stock Summary
Accustem Sciences competes with Tiziana Life, Acurx Pharmaceuticals, Alpha Cognition, and Aadi Bioscience. AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive HER2- breast cancer and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. Accustem Sciences is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 5 Penn Plaza, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.accustem.com |
| Currency | USD - US Dollar |
Accustem Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accustem Sciences's current stock value. Our valuation model uses many indicators to compare Accustem Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accustem Sciences competition to find correlations between indicators driving Accustem Sciences's intrinsic value. More Info.Accustem Sciences is number one stock in shares owned by insiders category among its peers. It is rated third in number of employees category among its peers creating about 0.07 of Number Of Employees per Shares Owned By Insiders. The ratio of Shares Owned By Insiders to Number Of Employees for Accustem Sciences is roughly 15.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Accustem Sciences' earnings, one of the primary drivers of an investment's value.Accustem Sciences Systematic Risk
Accustem Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Accustem Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Accustem Sciences correlated with the market. If Beta is less than 0 Accustem Sciences generally moves in the opposite direction as compared to the market. If Accustem Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Accustem Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Accustem Sciences is generally in the same direction as the market. If Beta > 1 Accustem Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Accustem Sciences December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Accustem Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Accustem Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Accustem Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Accustem OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Accustem Sciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 13.29 | |||
| Information Ratio | 0.0189 | |||
| Maximum Drawdown | 52.38 | |||
| Value At Risk | (20.37) | |||
| Potential Upside | 20.0 |
Additional Tools for Accustem OTC Stock Analysis
When running Accustem Sciences' price analysis, check to measure Accustem Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accustem Sciences is operating at the current time. Most of Accustem Sciences' value examination focuses on studying past and present price action to predict the probability of Accustem Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accustem Sciences' price. Additionally, you may evaluate how the addition of Accustem Sciences to your portfolios can decrease your overall portfolio volatility.